Neurosurgeons at Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI) are using MRI-guided laser technology to successfully ablate malignant brain tumors, becoming the first in the region to use this FDA-cleared system.
Saint Luke’s heart transplant program has performed its 600th heart transplant. Only 21 programs in the U.S. have performed more adult heart transplants.
Saint Luke’s Health System has been awarded a 2011 program grant from the March of Dimes Foundation to fund efforts to reduce the rate of elective early deliveries and the resulting health risks associated with preterm births.
Oncologists at Saint Luke's Cancer Institute are experiencing great success treating lung cancer patients with an innovative treatment called Stereotactic Body Radiation Therapy (SBRT).
The new Women’s Center at Saint Luke’s Hospital opened in spring 2010 and recently received its finishing touch – a graceful new sculpture at the exterior entrance to welcome patients and visitors.
Kim Smolderen, M.D., a post-doctoral fellow at Saint Luke's Mid America Heart Institute who is supported by the American Heart Association Pharmaceutical Roundtable/Spina Outcomes Research Center, has been awarded a Veni-grant.
Patients who are considered non-operable for conventional open heart valve surgery may have promising options using a new treatment available in the region only through Saint Luke's Mid America Heart Institute.
Expectant mothers planning to deliver their babies at Saint Luke's Hospital of Kansas City will soon be doing so in spacious, well-appointed new birthing suites.
